Xingkui Xue

438 total citations
19 papers, 335 citations indexed

About

Xingkui Xue is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Xingkui Xue has authored 19 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Oncology and 3 papers in Hematology. Recurrent topics in Xingkui Xue's work include RNA Interference and Gene Delivery (3 papers), Virus-based gene therapy research (2 papers) and Cancer Mechanisms and Therapy (2 papers). Xingkui Xue is often cited by papers focused on RNA Interference and Gene Delivery (3 papers), Virus-based gene therapy research (2 papers) and Cancer Mechanisms and Therapy (2 papers). Xingkui Xue collaborates with scholars based in China, United States and Germany. Xingkui Xue's co-authors include W. Christopher Shelley, Edward F. Srour, Nancy Pech, Mary C. Dinauer, Mervin C. Yöder, Zoltán Ivics, R. Scott McIvor, Tucker W. LeBien, Lajos Mátés and Zsuzsanna Izsvák and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of Agricultural and Food Chemistry.

In The Last Decade

Xingkui Xue

19 papers receiving 327 citations

Peers

Xingkui Xue
Chengxin Luo China
Geom-Seog Seo South Korea
Eralda Salataj United States
Martha B. Reich United States
Atsushi Matsui Japan
Ying Xie China
Yali Ding United States
A Lanza Italy
Xiaoling Yu China
Chengxin Luo China
Xingkui Xue
Citations per year, relative to Xingkui Xue Xingkui Xue (= 1×) peers Chengxin Luo

Countries citing papers authored by Xingkui Xue

Since Specialization
Citations

This map shows the geographic impact of Xingkui Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingkui Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingkui Xue more than expected).

Fields of papers citing papers by Xingkui Xue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xingkui Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingkui Xue. The network helps show where Xingkui Xue may publish in the future.

Co-authorship network of co-authors of Xingkui Xue

This figure shows the co-authorship network connecting the top 25 collaborators of Xingkui Xue. A scholar is included among the top collaborators of Xingkui Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xingkui Xue. Xingkui Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Hu, Xiao, Yanhua Li, Xisheng Wang, & Xingkui Xue. (2025). Role of M2 macrophage-derived exosomes in cancer drug resistance via noncoding RNAs. Discover Oncology. 16(1). 741–741. 3 indexed citations
2.
Jiang, Chunmei, et al.. (2024). Exploring the conformational dynamics and key amino acids in the CD26-caveolin-1 interaction and potential therapeutic interventions. Medicine. 103(22). e38367–e38367. 1 indexed citations
3.
4.
Jiang, Chunmei, Zhixiang Xu, Jin Li, et al.. (2023). Case report: Clinical and virological characteristics of aseptic meningitis caused by a recombinant echovirus 18 in an immunocompetent adult. Frontiers in Medicine. 9. 1094347–1094347. 3 indexed citations
5.
Hu, Xiao, et al.. (2023). Human dendritic cell subsets in the glioblastoma-associated microenvironment. Journal of Neuroimmunology. 383. 578147–578147. 6 indexed citations
6.
Wang, Xisheng, et al.. (2022). Therapeutic Perspectives of CD26 Inhibitors in Imune-Mediated Diseases. Molecules. 27(14). 4498–4498. 17 indexed citations
7.
8.
Wu, Bin, et al.. (2021). LncRNA LINC00115 facilitates lung cancer progression through miR‐607/ITGB1 pathway. Environmental Toxicology. 37(1). 7–16. 17 indexed citations
9.
Zhang, Tian, et al.. (2020). Generation of a FOXH1 homozygous knockout human embryonic stem cell line by CRISPR/Cas9 system. Stem Cell Research. 50. 102121–102121. 1 indexed citations
10.
Xue, Xingkui, et al.. (2019). Immunomodulatory Effect of Structurally Characterized Mushroom Sclerotial Polysaccharides Isolated from Polyporus rhinocerus on Bone Marrow Dendritic Cells. Journal of Agricultural and Food Chemistry. 67(43). 12137–12143. 28 indexed citations
11.
Altenburg, Jeffrey D., Shuhong Zhang, Xingkui Xue, & Sherif S. Farag. (2015). The synergistic anti-lymphoma effects of PIM kinase inhibitors in combination with DNA damaging agents.. Journal of Clinical Oncology. 33(15_suppl). e19522–e19522. 1 indexed citations
12.
13.
Zhao, Yi, Qiuyan Liu, Yang Li, et al.. (2012). TLR4 inactivation protects from graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Cellular and Molecular Immunology. 10(2). 165–175. 33 indexed citations
14.
Seitz, Gabriele, et al.. (2011). The G protein-coupled receptor CysLT1 mediates chemokine-like effects and prolongs survival in chronic lymphocytic leukemia. Leukemia & lymphoma. 53(4). 665–673. 13 indexed citations
15.
Zhang, Yuming, et al.. (2011). Administration of Sodium Ibandronate in the Treatment of Complicated Giant Cell Tumor of the Spine. Spine. 36(17). E1166–E1172. 18 indexed citations
16.
Xue, Xingkui, Nancy Pech, W. Christopher Shelley, et al.. (2010). Antibody targeting KIT as pretransplantation conditioning in immunocompetent mice. Blood. 116(24). 5419–5422. 58 indexed citations
17.
Zheng, Weiyan, Guoqing Wei, Xiujin Ye, et al.. (2009). Bortezomib in combination with dexamethasone and subsequent thalidomide for newly-diagnosed multiple myeloma: A Chinese experience. Leukemia Research. 33(12). 1615–1618. 12 indexed citations
18.
Xue, Xingkui, Xin Huang, Lajos Mátés, et al.. (2009). Stable gene transfer and expression in cord blood–derived CD34+ hematopoietic stem and progenitor cells by a hyperactive Sleeping Beauty transposon system. Blood. 114(7). 1319–1330. 103 indexed citations
19.
Xue, Xingkui, Zhen Cai, Gabriele Seitz, et al.. (2007). Differential Effects of G Protein–Coupled Receptors on Hematopoietic Progenitor Cell Growth Depend on their Signaling Capacities. Annals of the New York Academy of Sciences. 1106(1). 180–189. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chengxin Luo Breakdown of academic impact, for papers by Geom-Seog Seo Breakdown of academic impact, for papers by Eralda Salataj Breakdown of academic impact, for papers by Martha B. Reich Breakdown of academic impact, for papers by Atsushi Matsui Breakdown of academic impact, for papers by Ying Xie Breakdown of academic impact, for papers by Yali Ding Breakdown of academic impact, for papers by A Lanza Breakdown of academic impact, for papers by Xiaoling Yu
Rankless by CCL
2026